Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Kleanthis Xanthopoulos


Privately held transdermal drug delivery firm Zosano Pharma said it has appointed Kleanthis Xanthopoulos to its board of directors.

Xanthopolis is currently president and CEO of microRNA drug developer Regulus Therapeutics. Prior to that, he was a co-founder and president/CEO of Anadys Pharmaceuticals.